指南与共识泌尿系结石前列腺增生与排尿功能障碍前列腺癌

腔内泌尿外科与微创泌尿外科手术后阿片类药物处方建议:专家小组共识

Recommendations for Opioid Prescribing after Endourological and Minimally Invasive Urological Surgery: An Expert Panel Consensus.
指南 / 共识 · J Urol · 2019-08-29

该专家小组共识针对无慢性疼痛且未使用过阿片类药物的患者,采用改良德尔菲法为16种腔内泌尿外科与微创泌尿外科手术制定术后阿片类药物处方建议,以羟考酮5 mg当量定义片数;所有手术最低推荐片数均为0,最高推荐量从0片到15片不等,中位数10片,并识别出8项阿片类药物管理策略。

要点

  • 16种腔内泌尿外科与微创泌尿外科手术各有术后阿片类药物处方推荐。
  • 所有手术最低推荐阿片类药物片数均为0片,最高推荐量0至15片,中位数10片。
  • 专家组识别出8项阿片类药物管理策略,包括结合患者目标与偏好并最大化非阿片类治疗。

核心结论

  • 针对手术的术后阿片类药物处方指南可能有助于使泌尿外科医生的个体处方习惯与共识推荐保持一致,并可支持减少泌尿外科过度处方的质量改进工作。

研究设计与样本

  • 15人多学科专家小组,包括来自5个利益相关团体的代表,采用三步改良德尔菲法制定术后阿片类药物处方建议。
  • 建议针对无慢性疼痛状况且未使用过阿片类药物的患者,使用羟考酮5 mg当量定义处方片数。

主要发现

  • 为16种腔内泌尿外科与微创泌尿外科手术制定了手术特异性推荐。
  • 专家组一致认为并非所有患者都希望或需要使用阿片类药物,因此所有手术的最低推荐阿片类药物片数均为0。
  • 最高推荐量因手术而异,从0片(3种手术)到15片(6种手术),中位数为10片。
  • 主治泌尿外科医生投票选择的阿片类药物数量通常高于非主治专家组成员。
  • 专家组识别出8项阿片类药物管理策略,包括结合患者目标与偏好进行术后疼痛管理,以及最大化非阿片类药物治疗。

关键数值与推荐

  • 所有手术最低推荐阿片类药物片数为0片(羟考酮5 mg当量)。
  • 最高推荐量:0片(3种手术)至15片(6种手术),中位数10片。
  • 共识范围旨在使处方数量与预期需求相匹配。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Opioids are frequently overprescribed after surgery. The 2018 AUA position statement on opioid use suggests using the lowest dose and potency to achieve pain control but the lack of procedure specific prescribing guidelines contributes to wide variation in prescribing patterns. To address this gap we aimed to develop opioid prescribing recommendations through an expert panel consensus. MATERIALS AND METHODS: The 15-member multidisciplinary expert panel included representatives from 5 stakeholder groups. A 3-step modified Delphi method was used to develop recommendations for postoperative opioid prescribing. Recommendations were made for opioid naïve patients without chronic pain conditions. The panel used oxycodone 5 mg equivalents to define the number of prescribed tablets. RESULTS: Procedure specific recommendations were developed for 16 endourological and minimally invasive urological procedures. The panel agreed that not all patients desire or require opioids and, thus, the minimum recommended number of opioid tablets for all procedures was 0. Consensus ranges were identified to allow prescribed quantities to be aligned with expected needs. The maximum recommended quantity varied by procedure from 0 tablets (3 procedures) to 15 tablets (6 procedures) with a median of 10 tablets. Attending urologists typically voted for higher opioid quantities than nonattending panel members. The panel identified 8 overarching strategies for opioid stewardship, including contextualizing postoperative pain management with patient goals and preferences, and maximizing nonopioid therapies. CONCLUSIONS: Procedure specific guidelines for postoperative opioid prescribing may help align individual urologist prescribing habits with consensus recommendations. These guidelines can aid quality improvement efforts to reduce overprescribing in urology.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Koo K, Faisal F, Gupta N, et al. Recommendations for Opioid Prescribing after Endourological and Minimally Invasive Urological Surgery: An Expert Panel Consensus. J Urol. 2019. PMID: 31464563. doi:10.1097/JU.0000000000000514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。